Office of the Director, National Institutes of Health; Notice of Meeting, 43669 [2021-17012]

Download as PDF Federal Register / Vol. 86, No. 151 / Tuesday, August 10, 2021 / Notices 9. TEKTURNA (aliskiren hemifumarate) 10. VIMOVO (naproxen/esomeprazole magnesium) 11. VIREAD (tenofovir disoproxil fumarate) 12. XOFLUZA (baloxavir marboxil) Center for Devices and Radiological Health 1. CONTEGRA PULMONARY VALVED CONDUIT (Humanitarian Device Exemption (HDE)) 2. ELANA SURGICAL KIT (HDE) 3. ENTERRA THERAPY SYSTEM (HDE) 4. LIPOSORBER LA–15 SYSTEM (HDE) 5. MEDTRONIC ACTIVA DYSTONIA THERAPY (HDE) 6. MINIMALLY INVASIVE DEFORMITY CORRECTION (MID–C) SYSTEM 7. PLEXIMMUNE IN–VITRO DIAGNOSTIC TEST (HDE) 8. PULSERIDER ANEURYSM NECK RECONSTRUCTION DEVICE (HDE) 9. THE TETHER—VERTEBRAL BODY TETHERING SYSTEM Dated: August 5, 2021. Lauren K. Roth, Acting Principal Associate Commissioner for Policy. [FR Doc. 2021–17041 Filed 8–9–21; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jbell on DSKJLSW7X2PROD with NOTICES Office of the Director, National Institutes of Health; Notice of Meeting Notice is hereby given of a meeting of the HEAL (Helping to End Addiction Long-Term) Multi-Disciplinary Working Group. The meeting will be open to the public as indicated below via NIH Videocast. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The program documents and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the program documents, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: HEAL MultiDisciplinary Working Group (MDWG) Meeting. VerDate Sep<11>2014 17:05 Aug 09, 2021 Jkt 253001 Date: September 1–2, 2021. Open: September 01, 2021, 10:30 a.m. to 11:30 a.m. Closed: September 02, 2021, 11:30 a.m. to 4:30 p.m. Closed: September 02, 2021, 10:30 a.m. to 3:45 p.m. Agenda: Provide an update on Helping to End Addiction Long-Term (HEAL) Initiative projects and obtain expertise from MDWG relevant to the NIH HEAL Initiative and to specific HEAL projects. Videocast: The open portion of the meeting will be live webcast at: https:// videocast.nih.gov/. Place: National Institutes of Health, Building 1, Wilson Hall, 1 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Rebecca G Baker, Ph.D., Office of the Director, National Institutes of Health, 1 Center Drive, Room 103A, Bethesda, MD 20892, (301) 402–1994, Rebecca.baker@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Office of the Director for the NIH HEAL Initiative website: https://heal.nih.gov/news where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: August 5, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–17012 Filed 8–9–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. URL for virtual access:—https:// videocast.nih.gov/watch=42556 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Name of Committee: Center for Scientific Review Advisory Council. Date: September 27, 2021. Time: 1:00 p.m. to 4:30 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9159, reedbr@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/AboutCSR/Organization/ CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 5, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–17043 Filed 8–9–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Listing of Members of the National Institutes of Health’s Senior Executive Service 2021 Performance Review Board (PRB) AGENCY: National Institutes of Health, HHS. ACTION: Notice. The National Institutes of Health (NIH) announces the persons who will serve on the National Institutes of Health’s Senior Executive Service 2021 Performance Review Board. FOR FURTHER INFORMATION CONTACT: For further information about the NIH Performance Review Board, contact Mr. Kha Nguyen, Director, Division of Senior and Scientific Executive Management, Office of Human Resources, National Institutes of Health, Building 31, Room 1C31P, Bethesda, Maryland 20892, telephone 301.594.3022 (not a toll-free number), email kha.nguyen@nih.gov. SUPPLEMENTARY INFORMATION: This action is being taken in accordance with SUMMARY: Center for Scientific Review; Notice of Meeting 43669 E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 86, Number 151 (Tuesday, August 10, 2021)]
[Notices]
[Page 43669]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17012]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Notice is hereby given of a meeting of the HEAL (Helping to End 
Addiction Long-Term) Multi-Disciplinary Working Group.
    The meeting will be open to the public as indicated below via NIH 
Videocast. Individuals who need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the Contact Person listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The program documents and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the program documents, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: HEAL Multi-Disciplinary Working Group (MDWG) 
Meeting.
    Date: September 1-2, 2021.
    Open: September 01, 2021, 10:30 a.m. to 11:30 a.m.
    Closed: September 02, 2021, 11:30 a.m. to 4:30 p.m.
    Closed: September 02, 2021, 10:30 a.m. to 3:45 p.m.
    Agenda: Provide an update on Helping to End Addiction Long-Term 
(HEAL) Initiative projects and obtain expertise from MDWG relevant 
to the NIH HEAL Initiative and to specific HEAL projects.
    Videocast: The open portion of the meeting will be live webcast 
at: https://videocast.nih.gov/.
    Place: National Institutes of Health, Building 1, Wilson Hall, 1 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Rebecca G Baker, Ph.D., Office of the Director, 
National Institutes of Health, 1 Center Drive, Room 103A, Bethesda, 
MD 20892, (301) 402-1994, [email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Office of the Director for 
the NIH HEAL Initiative website: https://heal.nih.gov/news where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: August 5, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17012 Filed 8-9-21; 8:45 am]
BILLING CODE 4140-01-P